Secondary thyroid carcinoma after allogeneic bone marrow transplantation during childhood

A. Cohen, A. Rovelli, M. T. van Lint, F. Merlo, A. Gaiero, R. Mulas, A. Balduzzi, P. Corti, C. Uderzo, A. Bacigalupo

Research output: Contribution to journalArticle

Abstract

The aim of this study was to evaluate the incidence and risk factors related to secondary thyroid carcinoma (STC) in patients who have undergone allogeneic BMT during childhood. Data related to the primary hematological disorder and BMT procedure were obtained from the records of 113 patients (42 F; 71 M) who underwent BMT before the age of 18 (median 10.0 years; range 1.7-18.0) and survived more than 3 years after transplant with a median follow-up of 10.1 years (range 3.0-19.0). Sixteen received cranial radiation (CRT) during first-line treatment. Pre-transplant conditioning included TBI in 85 patients, TAI in two, while 26 children did not receive irradiation. The standardized incidence ratio of STC after BMT was significantly higher (P <0.001) than that of the general population. STC was found in eight patients, 3.1 to 15.7 years after transplant. All received TBI and three also CRT. The Cox's regression analysis, although not statistically significant due to the small study population, showed an increased risk in those who had received a cumulative radiation dose higher than 10 Gy and in those who developed chronic GVHD. Careful follow-up of thyroid status including annual ultrasound examination is recommended for early detection of tumor.

Original languageEnglish
Pages (from-to)1125-1128
Number of pages4
JournalBone Marrow Transplantation
Volume28
Issue number12
DOIs
Publication statusPublished - 2001

Fingerprint

Homologous Transplantation
Bone Marrow Transplantation
Thyroid Neoplasms
Radiation
Transplants
Incidence
Population
Thyroid Gland
Regression Analysis
Neoplasms
Therapeutics

Keywords

  • Bone marrow transplantation
  • Children
  • Irradiation
  • Late effects
  • Secondary tumors
  • Thyroid carcinoma

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

Secondary thyroid carcinoma after allogeneic bone marrow transplantation during childhood. / Cohen, A.; Rovelli, A.; van Lint, M. T.; Merlo, F.; Gaiero, A.; Mulas, R.; Balduzzi, A.; Corti, P.; Uderzo, C.; Bacigalupo, A.

In: Bone Marrow Transplantation, Vol. 28, No. 12, 2001, p. 1125-1128.

Research output: Contribution to journalArticle

Cohen, A, Rovelli, A, van Lint, MT, Merlo, F, Gaiero, A, Mulas, R, Balduzzi, A, Corti, P, Uderzo, C & Bacigalupo, A 2001, 'Secondary thyroid carcinoma after allogeneic bone marrow transplantation during childhood', Bone Marrow Transplantation, vol. 28, no. 12, pp. 1125-1128. https://doi.org/10.1038/sj.bmt.1703290
Cohen, A. ; Rovelli, A. ; van Lint, M. T. ; Merlo, F. ; Gaiero, A. ; Mulas, R. ; Balduzzi, A. ; Corti, P. ; Uderzo, C. ; Bacigalupo, A. / Secondary thyroid carcinoma after allogeneic bone marrow transplantation during childhood. In: Bone Marrow Transplantation. 2001 ; Vol. 28, No. 12. pp. 1125-1128.
@article{b078986359d84de7ae6ba9dd3e075ca7,
title = "Secondary thyroid carcinoma after allogeneic bone marrow transplantation during childhood",
abstract = "The aim of this study was to evaluate the incidence and risk factors related to secondary thyroid carcinoma (STC) in patients who have undergone allogeneic BMT during childhood. Data related to the primary hematological disorder and BMT procedure were obtained from the records of 113 patients (42 F; 71 M) who underwent BMT before the age of 18 (median 10.0 years; range 1.7-18.0) and survived more than 3 years after transplant with a median follow-up of 10.1 years (range 3.0-19.0). Sixteen received cranial radiation (CRT) during first-line treatment. Pre-transplant conditioning included TBI in 85 patients, TAI in two, while 26 children did not receive irradiation. The standardized incidence ratio of STC after BMT was significantly higher (P <0.001) than that of the general population. STC was found in eight patients, 3.1 to 15.7 years after transplant. All received TBI and three also CRT. The Cox's regression analysis, although not statistically significant due to the small study population, showed an increased risk in those who had received a cumulative radiation dose higher than 10 Gy and in those who developed chronic GVHD. Careful follow-up of thyroid status including annual ultrasound examination is recommended for early detection of tumor.",
keywords = "Bone marrow transplantation, Children, Irradiation, Late effects, Secondary tumors, Thyroid carcinoma",
author = "A. Cohen and A. Rovelli and {van Lint}, {M. T.} and F. Merlo and A. Gaiero and R. Mulas and A. Balduzzi and P. Corti and C. Uderzo and A. Bacigalupo",
year = "2001",
doi = "10.1038/sj.bmt.1703290",
language = "English",
volume = "28",
pages = "1125--1128",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",
number = "12",

}

TY - JOUR

T1 - Secondary thyroid carcinoma after allogeneic bone marrow transplantation during childhood

AU - Cohen, A.

AU - Rovelli, A.

AU - van Lint, M. T.

AU - Merlo, F.

AU - Gaiero, A.

AU - Mulas, R.

AU - Balduzzi, A.

AU - Corti, P.

AU - Uderzo, C.

AU - Bacigalupo, A.

PY - 2001

Y1 - 2001

N2 - The aim of this study was to evaluate the incidence and risk factors related to secondary thyroid carcinoma (STC) in patients who have undergone allogeneic BMT during childhood. Data related to the primary hematological disorder and BMT procedure were obtained from the records of 113 patients (42 F; 71 M) who underwent BMT before the age of 18 (median 10.0 years; range 1.7-18.0) and survived more than 3 years after transplant with a median follow-up of 10.1 years (range 3.0-19.0). Sixteen received cranial radiation (CRT) during first-line treatment. Pre-transplant conditioning included TBI in 85 patients, TAI in two, while 26 children did not receive irradiation. The standardized incidence ratio of STC after BMT was significantly higher (P <0.001) than that of the general population. STC was found in eight patients, 3.1 to 15.7 years after transplant. All received TBI and three also CRT. The Cox's regression analysis, although not statistically significant due to the small study population, showed an increased risk in those who had received a cumulative radiation dose higher than 10 Gy and in those who developed chronic GVHD. Careful follow-up of thyroid status including annual ultrasound examination is recommended for early detection of tumor.

AB - The aim of this study was to evaluate the incidence and risk factors related to secondary thyroid carcinoma (STC) in patients who have undergone allogeneic BMT during childhood. Data related to the primary hematological disorder and BMT procedure were obtained from the records of 113 patients (42 F; 71 M) who underwent BMT before the age of 18 (median 10.0 years; range 1.7-18.0) and survived more than 3 years after transplant with a median follow-up of 10.1 years (range 3.0-19.0). Sixteen received cranial radiation (CRT) during first-line treatment. Pre-transplant conditioning included TBI in 85 patients, TAI in two, while 26 children did not receive irradiation. The standardized incidence ratio of STC after BMT was significantly higher (P <0.001) than that of the general population. STC was found in eight patients, 3.1 to 15.7 years after transplant. All received TBI and three also CRT. The Cox's regression analysis, although not statistically significant due to the small study population, showed an increased risk in those who had received a cumulative radiation dose higher than 10 Gy and in those who developed chronic GVHD. Careful follow-up of thyroid status including annual ultrasound examination is recommended for early detection of tumor.

KW - Bone marrow transplantation

KW - Children

KW - Irradiation

KW - Late effects

KW - Secondary tumors

KW - Thyroid carcinoma

UR - http://www.scopus.com/inward/record.url?scp=0035697190&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035697190&partnerID=8YFLogxK

U2 - 10.1038/sj.bmt.1703290

DO - 10.1038/sj.bmt.1703290

M3 - Article

C2 - 11803353

AN - SCOPUS:0035697190

VL - 28

SP - 1125

EP - 1128

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - 12

ER -